Ann: ACTION3 IND Approved in China, page-219

Thanks for the link Vintage.

I think also that macro news out of the US yesterday & reading news regarding renewed positivity around the biotech sector for 2024 (yes we have been so slammed), so there could potentially be a few factors at play here, including existing licensing deal & potentially more to come prior to March 2024.

Of course that is not a given, but after our surprise at the last one out of the blue - discussions had been going on for some time as per company presentations, so now maybe investors are taking those words seriously.

Have a great day folks, & I guess when you get into that mindset of not having huge expectations with SP, even a bit cynical from past experiences (biotech investors), when something positive happens, it’s almost a bit hard to believe at first, but I think that is self-protective instinct after what biotech investors have endured over the last couple of years. We want our adrenaline/Dopamine rushes back!